Medicines and Healthcare products Regulatory Agency
Regulatory Agency
- Alerts, recalls and safety information: medicines and medical devices
- Drug Safety Update
- Yellow Card: Report a problem with a medicine or medical device
- Marketing authorisations and licensing guidance
- Product information about medicines
- Medical devices regulation and safety
- Latest information for patients
- MHRA guidance on coronavirus (COVID-19)
- About MHRA
- Have your say: we want to hear from healthcare professionals
- All MHRA services and information
Featured
Patients, carers and healthcare professionals with kits of the opioid overdose medicine Prenoxad Injection must visually check for the presence of two needles inside their kit. Any kits that do not have two needles should be returned for a replacement
Second Pfizer/BioNTech bivalent COVID-19 booster vaccine approved by UK medicines regulator
News story
This adapted COVID-19 vaccine targets both the original virus and the Omicron BA.4 and BA.5 sub-variants.
Every report to MHRA’s Yellow Card scheme helps improve the safety of medicines and medical devices for all
Press release
To improve medical product safety for all, report suspected side effects and adverse incidents as part of the #MedSafetyWeek global campaign
Patients urged to check packs of Targocid 200mg after two batches found to be contaminated
Press release
Patients using antibiotic Targocid 200mg powder at home must check if the batch number of their medicine is 0J25D1 or 0J25D2. Anyone who has one of these two batches should stop their treatment and seek immediate medical advice
Unique opportunity for healthcare professionals to influence future MHRA safety communications and safety reporting systems
Press release
Healthcare professionals asked to share their views on how they want to receive safety information from the UK medicines and medical devices regulator
Mental health funding of £1.8m welcomed by MHRA and NICE to explore regulation of digital mental health tools
Press release
The Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have been awarded £1.8m funding by Wellcome over three years to explore and produce guidance on regulating digital mental health tools.
Latest from the Medicines and Healthcare products Regulatory Agency
What we do
The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK.
MHRA is an executive agency, sponsored by the Department of Health and Social Care.
Follow us
Documents
Services
See all servicesPolicy papers and consultations
- Consultation on how MHRA communicate with healthcare professionals to improve medicines and medical devices’ safety
- Consultation on a new Code of Practice for the Expert Advisory Committees
Transparency and freedom of information releases
- Clinical trials for medicines: authorisation assessment performance
- The Medicines and Healthcare products Regulatory Agency Delivery Plan 2021-2023
Our management
Contact MHRA
General enquiries
10 South Colonnade
London
E14 4PU
United Kingdom
Telephone
020 3080 6000
Fax
020 3118 9803
Office hours are Monday to Friday, 9am to 5pm.
Media enquiries
MHRA
10 South Colonnade
London
E14 4PU
United Kingdom
During office hours:
020 3080 7651 (08:30 - 17:00)
Out of office hours:
07770 446 189 (17:00 - 08:30)
Office hours are Monday to Friday, 8:30am to 5pm. For real-time updates including the latest press releases and news statements, see our Twitter channel at https://www.twitter.com/mhragovuk
Make an FOI request
- Read about the Freedom of Information (FOI) Act and how to make a request.
- Check our previous releases to see if we’ve already answered your question.
- Make a new request by contacting us using the details below.
Freedom of Information
10 South Colonnade
London
E14 4PU
United Kingdom
Corporate information
Jobs and contracts